Sanai Health Industry Group Company (HKG:1889) has filed a second appeal seeking to overturn a civil judgment requiring it to honor payments under a finance lease and related guarantees, according to a Friday filing with the Hong Kong Stock Exchange.
In April, the No. 4 Intermediate People's Court of Beijing upheld Sanai Health's obligation to pay 67.4 million yuan in principal, 57.6 million yuan in default interest, 2.9 million yuan in penalties, and legal and insurance fees owed by its former subsidiary, Fujian Sanai Pharmaceutical.
In its latest appeal, Sanai Health asked the High People's Court of Beijing to declare the finance lease and guarantee agreements invalid and to dismiss all claims.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.